At first, Nour Mansour was thrilled by the effects of weight-loss jab Mounjaro - dropping from a size 18 to a size 8 in less ...

Ali Eastburn was looking forward to her son's wedding when her side-effects from weight loss drugs went from bad to worse ...

The Indian pharmaceutical market (IPM) registered a growth of 7.9 percent in July 2025, and cardiac and anti-diabetes therapy ...

Ideals of what beauty is, exacerbated by social media and artificial intelligence, has the potential to harm women's health – ...

One in five older Indian adults had diabetes in 2019, says a Lancet study. What are the key highlights of the study? What is ...

Even if shifts occur within the anti-diabetes segment, such as therapies moving from the top to the bottom of the market ...

Now, Eli Lilly says its experimental GLP-1 pill is a success after the first phase-three trial. The company said more than 3,000 adults on the experimental oral medication lowered their weight by an ...

Significant regulatory advances for lead candidate EB613 streamline Phase 3 clinical development and reduce regulatory hurdles. These 10 stocks could mint the next wave of millionaires › Entera Bio ...

Eli Lilly’s GLP-1 pill helped some participants lose up to 15% body weight. But is it as effective as the injection? Here's ...

Scientists have found new evidence that Ozempic can help reverse aging — yet another health benefit added to the laundry list ...

Indianapolis-based Eli Lilly and Co. shares fell Thursday, Aug. 7 following the pharmaceutical company's second-quarter ...

Some restaurants are offering smaller menu items to GLP-1 drug users, who eat less when dining out, per The New York Times.